Skip to main content
Premium Trial:

Request an Annual Quote

MWG Biotech Total 2004 Revenues Decline 23.2 Percent

NEW YORK, March 25 (GenomeWeb News) - MWG Biotech this week reported total revenues of €33 million for 2004, down €10 million from €43 million in 2003.


The Ebersberg, Germany-based company did not report fourth quarter revenues, but attributed its 23.2 percent year on year loss the divestment and eventual sales of its Genomic Diagnosis (microarrays) and Genomic Technology (lab automation) units.


Still, MWG reported that its two core units, Genomic Synthesis and Genomic Information, also did not perform as well in 2004, bringing in €23.5 million in total receipts, compared to €27 million from the year prior.


MWG did not report R&D costs. The company said that as of Dec. 31, 2004, it had €9.2 million cash, down from €11.5 million at the end of 2003.


MWG said in a statement that it would continue to pare its workforce down to 165 employees from 285 through the first half of 2005. The company began cutting its workforce in October 2004 when it made the decision to divest from its microarray and lab-automation units.Since then it has also closed subsidiaries in Ireland, Denmark, Italy, France, and the UK, though last week it signed on an Italian distributor, M-Medical.


MWG Biotech completed the sale of its Genomic Diagnosis unit to Ocimum Biosolutions in February, following the sale of its Genomic Technology unit to Aviso the same month. Financial details of both deals were not disclosed.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.